News | Cardiovascular Ultrasound | April 17, 2017

Cardiovascular Institute of the South Upgrades Cardiac Ultrasound With New Toshiba Medical Systems

Health system purchases 20 new Aplio 300 Platinum CV ultrasound systems, upgrades 20 existing system

Cardiovascular Institute of the South Upgrades Cardiac Ultrasound With New Toshiba Medical Systems

April 17, 2017 — To bolster its technology and treatment capabilities for coronary and peripheral artery diseases across all of its locations, Cardiovascular Institute of the South (CIS) installed 20 new Aplio 300 Platinum CV ultrasound systems from Toshiba Medical. CIS also upgraded 20 existing ultrasounds to Toshiba Medical’s Aplio 300 Platinum platform to ensure staff were offering consistent and more confident cardiac diagnoses to all patients.

“Purchasing ultrasound systems that are extremely easy to use and installing them across all of our facilities to make exams consistent was very important to us,” said Jaime Aubin, ultrasound team leader, Cardiovascular Institute of the South. “The Aplio 300 Platinum and Aplio 300 Platinum CV ultrasounds offer the best image quality and the cardiac applications we need to make it easier for sonographers of all levels of experience to easily capture images with little to no pressure to the body, improving patient comfort. Toshiba Medical has also been an excellent partner in training all of our staff, as well as helping us create custom reports that fully integrate with our EMR [electronic medical record] platform.”

The Aplio 300 Platinum CV offers a comprehensive suite of dedicated-cardiac technologies, featuring 2-D Wall Motion Tracking, spectral and color Doppler, and Toshiba Medical’s latest suite of guidance and workflow technologies. Delivering detail and resolution throughout the entire field-of-view, the system provides excellent definition of the endocardium, which results in an accurate and easy-to-use 2-D strain resolution. Furthermore, Toshiba Medical’s Wall Motion Tracking technology allows providers to quantify isolated movement within the heart to assist with detection of cardiotoxicity.

The Aplio 300 Platinum features a high-resolution 19-inch monitor and an optional fourth transducer port. The system also includes advanced imaging features, such as Advanced Dynamic Flow (ADF), Differential Tissue Harmonics (D-THI), Precision Imaging and ApliPure+. In addition, BEAM needle visualization allows for better procedural accuracy leading to a better overall customer experience.

For more information:

Related Content

Siemens Healthineers Introduces Portable Cardiovascular-Dedicated Ultrasound at ACC.18
News | Cardiovascular Ultrasound | March 13, 2018
At the American College of Cardiology’s (ACC) 67th Annual Scientific Session and Expo, March 10-12 in Orlando, Fla.,...
ASE Participating in Global Study to Establish New Standardization in Cardiovascular Ultrasound
News | Cardiovascular Ultrasound | February 26, 2018
February 26, 2018 – The American Society of Echocardiography (ASE) and its International Alliance Partners are joinin
Dr. Bijoy Khandheria, a cardiologist from Aurora Health in Milwaukee, explains a cardiac echo image with a patient.

Dr. Bijoy Khandheria, a cardiologist from Aurora Health in Milwaukee, explains a cardiac echo image with a patient during the Fox video segment. 

News | Cardiovascular Ultrasound | February 09, 2018
Fox Business News recently featured GE Healthcare’s ultrasound technologies in a 6-minute segment with the Innovation
ASE Opens Enrollment for ImageGuideEcho Registry
News | Cardiovascular Ultrasound | January 29, 2018
January 29, 2018 — The American Society of Echocardiography (ASE) announced that ImageGuideEcho, a module under the I
New Vascular Ultrasound Registry Looks to Enhance Patient Care
News | Cardiovascular Ultrasound | January 17, 2018
The Society for Vascular Ultrasound (SVU), the Society for Vascular Surgery (SVS) and Medstreaming-M2S announced the...
New International Report Provides Comprehensive Guide to Imaging in Chagas Heart Disease
News | Cardiovascular Ultrasound | January 03, 2018
Chagas disease (ChD), an infectious parasitic disease transmitted primarily by triatomine insects, has become a...
Bay Labs Completes $5.5 Million Series A Financing for AI-Driven Ultrasound
News | Cardiovascular Ultrasound | December 21, 2017
December 21, 2017 — Bay Labs, a medical technology company applying...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
Videos | Cardiovascular Ultrasound | October 12, 2017
Sharon Mulvagh, M.D., FRCPC, FACC, FAHA, FASE, professor, Division of Cardiology, Department of Medicine, Dalhousie U
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound | September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
Overlay Init